Ellen de Kort

37 Sedation for the INSURE procedure 2 17. Welzing L, Kribs A, Eifinger F, Huenseler C, Oberthuer A, Roth B. Propofol as an induction agent for endotracheal intubation can cause significant arterial hypotension in preterm neonates. Paediatr Anaesth. 2010;20:605-611. 18. Flor-de-Lima F, Rocha G, Guimaraes H. Impact of changes in perinatal care on neonatal respiratory outcome and survival of preterm newborns: an overview of 15 years. Crit Care Res Pract 2012;2012:643246. doi: 10.1155/2012/643246. 19. Verder H, Robertson B, Greisen G, Ebbesen F, Albertsen P, Lundstrøm, et al.; Danish-Swedish multicenter study group. Surfactant therapy and nasal continuous airway pressure for newborns with respiratory distress syndrome. NJEM 1994;133:1051-1055. 20. Cherif A, Hachani C, Khrouf N. Risk factors of the failure of surfactant treatment by transient intubation during nasal continuous positive airway pressure in preterm infants. Am J Perinatol 2008;25:647-652. 21. Verder H, Albertsen P, Ebbesen F, Greisen G, Robertson B, Bertelsen A, et al. Nasal continuous positive airway pressure and early surfactant therapy for respiratory distress syndrome in newborns of less than 30 weeks’ gestation. Pediatrics 1999;103:e24. 22. Van den Berg E, Lemmers PM, Toet MC, Klaessens JH, van Bel F. Effect of the “INSURE” procedure on cerebral oxygenation and electric brain activity of the preterm infants. Arch Dis Child Fetal Neonatal Ed 2010;95:F53-F58. 23. Bohlin K, Gudmundsdottir T, Katz-Salamon M, Jonsson B, Blennow M. Implementation of surfactant treatment during continuous positive airway pressure. J Perinatol 2007;27:422-427. 24. Sandri F, Ancora G, Lanzoni A, Tagliabue P, Colnaghi M, Ventura ML, et al. Prophylactic nasal continuous positive airway pressure in newborns of 28-31 weeks gestation: multicentre randomised controlled clinical trial. Arch Dis Child Fetal Neonatal Ed 2004;89:F394-F398. 25. Gizzi C, Papoff P, Giordano I, Massenzi L, Barbara CS, Campelli M, et al. Flow-synchronized nasal intermittent positive pressure ventilation for infants < 32 weeks’ gestation with respiratory distress syndrome. Crit Care Res Pract 2012;2012:301818. doi: 10.1155/2012/ 301818. 26. Ancora G, Maranella E, Grandi S, Pierantoni L, Guglielmi M, Faldella G. Role of bilevel positive airway pressure in the management of preterm newborns who have received surfactant. Acta Paediatr 2010;99:1807-1811. 27. Leone F, Trevisanuto D, Cavallin F, Parotto M, Zanardo V. Efficacy of INSURE during nasal CPAP in preterm infants with respiratory distress syndrome. Minerva Pediatr 2013;65:187-192. 28. Penido MG, De Oliveira Silva DF, Tavares EC, E Silva YP. Propofol versus midazolam for intubating preterm neonates: a randomized controlled trial. J Perinatol 2011;31:356-360. 29. Davis PF, Cladis FP. The use of ultra-short-acting opioids in paediatric anaesthesia: the role of remifentanil. Clin Pharmacokinet 2005;44:787-796. 30. Choong K, AlFaleh K, Doucette J, Gray S, Rich B, Verhey L et al. Remifentanil for endotracheal intubation in neonates: a randomized controlled trial. Arch Dis Child Fetal Neonatal Ed 2010;95:F80-F84. 31. Penido MG, Garaa R, Sammartino M, Pereira e Silva Y. Remifentanil in neonatal intensive care and anaesthesia practice. Acta Paediatr 2010;99:1454-1463. 32. Welzing L, Roth B. Experience with remifentanil in neonates and infants. Drugs 2006;66:1339- 1350. 33. Lago P, Tiozzo C, Boccuzzo G, Allegro A, Zacchello F. Remifentanil for percutaneous intravenous central catheter placement in preterm infants: a randomized controlled trial. Paediatr Anaesth 2008;18:736-744.